Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BOPH
Bohai Pharmaceuticals Group
$0.00
$0.00
$0.00
$0.00
$20K1.7830,425 shs50,000 shs
MusclePharm Co. stock logo
MSLP
MusclePharm
$0.00
$0.00
$0.00
$7K-0.0726,442 shsN/A
NexImmune, Inc. stock logo
NEXI
NexImmune
$0.01
+4,900.0%
$0.00
$0.00
$1.01
$14K2.045,993 shs450 shs
Optec International, Inc. stock logo
OPTI
Optec International
$0.00
$0.00
$0.00
$0.00
$13KN/A1.05 million shs175,232 shs
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BOPH
Bohai Pharmaceuticals Group
0.00%0.00%0.00%0.00%0.00%
MusclePharm Co. stock logo
MSLP
MusclePharm
0.00%0.00%0.00%0.00%-83.33%
NexImmune, Inc. stock logo
NEXI
NexImmune
0.00%+4,900.00%+4,900.00%+9,900.00%-97.37%
Optec International, Inc. stock logo
OPTI
Optec International
0.00%-26.67%-31.25%-31.25%+37.50%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BOPH
Bohai Pharmaceuticals Group
$0.00
$0.00
$0.00
$0.00
$20K1.7830,425 shs50,000 shs
MusclePharm Co. stock logo
MSLP
MusclePharm
$0.00
$0.00
$0.00
$7K-0.0726,442 shsN/A
NexImmune, Inc. stock logo
NEXI
NexImmune
$0.01
+4,900.0%
$0.00
$0.00
$1.01
$14K2.045,993 shs450 shs
Optec International, Inc. stock logo
OPTI
Optec International
$0.00
$0.00
$0.00
$0.00
$13KN/A1.05 million shs175,232 shs
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BOPH
Bohai Pharmaceuticals Group
0.00%0.00%0.00%0.00%0.00%
MusclePharm Co. stock logo
MSLP
MusclePharm
0.00%0.00%0.00%0.00%-83.33%
NexImmune, Inc. stock logo
NEXI
NexImmune
0.00%+4,900.00%+4,900.00%+9,900.00%-97.37%
Optec International, Inc. stock logo
OPTI
Optec International
0.00%-26.67%-31.25%-31.25%+37.50%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BOPH
Bohai Pharmaceuticals Group
0.00
N/AN/AN/A
MusclePharm Co. stock logo
MSLP
MusclePharm
0.00
N/AN/AN/A
NexImmune, Inc. stock logo
NEXI
NexImmune
0.00
N/AN/AN/A
Optec International, Inc. stock logo
OPTI
Optec International
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BOPH
Bohai Pharmaceuticals Group
N/AN/AN/AN/AN/AN/A
MusclePharm Co. stock logo
MSLP
MusclePharm
$50.04M0.00N/AN/A($0.94) per share0.00
NexImmune, Inc. stock logo
NEXI
NexImmune
N/AN/AN/AN/A$3.32 per shareN/A
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BOPH
Bohai Pharmaceuticals Group
N/AN/A0.00N/AN/AN/AN/AN/A
MusclePharm Co. stock logo
MSLP
MusclePharm
-$12.87M-$0.58N/AN/AN/A-38.51%N/A-169.56%N/A
NexImmune, Inc. stock logo
NEXI
NexImmune
-$32.34M-$18.54N/AN/AN/A-534.32%-213.72%N/A
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BOPH
Bohai Pharmaceuticals Group
N/AN/AN/AN/AN/A
MusclePharm Co. stock logo
MSLP
MusclePharm
N/AN/AN/AN/AN/A
NexImmune, Inc. stock logo
NEXI
NexImmune
N/AN/AN/AN/AN/A
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BOPH
Bohai Pharmaceuticals Group
N/AN/AN/A
MusclePharm Co. stock logo
MSLP
MusclePharm
N/A
0.25
0.23
NexImmune, Inc. stock logo
NEXI
NexImmune
N/A
0.66
0.66
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
BOPH
Bohai Pharmaceuticals Group
N/A
MusclePharm Co. stock logo
MSLP
MusclePharm
15.49%
NexImmune, Inc. stock logo
NEXI
NexImmune
9.85%
Optec International, Inc. stock logo
OPTI
Optec International
N/A

Insider Ownership

CompanyInsider Ownership
BOPH
Bohai Pharmaceuticals Group
N/A
MusclePharm Co. stock logo
MSLP
MusclePharm
60.70%
NexImmune, Inc. stock logo
NEXI
NexImmune
14.90%
Optec International, Inc. stock logo
OPTI
Optec International
50.34%
CompanyEmployeesShares OutstandingFree FloatOptionable
BOPH
Bohai Pharmaceuticals Group
N/A19.52 millionN/ANot Optionable
MusclePharm Co. stock logo
MSLP
MusclePharm
2033.39 million13.12 millionNot Optionable
NexImmune, Inc. stock logo
NEXI
NexImmune
61.40 million1.19 millionNot Optionable
Optec International, Inc. stock logo
OPTI
Optec International
111.65 millionN/ANot Optionable

Recent News About These Companies

Optec International, Inc. (OPTI) - Yahoo Finance
Optec International Inc.
Optec Technology Ltd.
New Optec CEO Updates Shareholders
New Optec CEO Updates Shareholders
SITC International Expands Fleet with New Vessel Orders
Opti Digital Welcomes Guillem Fiter as Chief Marketing Officer
OGP exhibiting exciting lineup of metrology systems at IMTS 2024
Global Optical Coherence Tomography Industry

New MarketBeat Followers Over Time

Bohai Pharmaceuticals Group OTCMKTS:BOPH

$0.0010 0.00 (0.00%)
As of 03/11/2019

Bohai Pharmaceuticals Group, Inc. engages in the production, manufacture, and distribution of herbal pharmaceuticals based on traditional Chinese medicine. Its products include lung nourishing syrup, tongbi capsules, tongbi tablets, zhuangyuanshenhailong medicinal wine, bazhenyimu cream, fangfengtongsheng granule, and zhengxintai capsules. The company was founded on January 9, 2008 and is headquartered in Yantai, China.

MusclePharm stock logo

MusclePharm OTCMKTS:MSLP

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.

NexImmune stock logo

NexImmune NASDAQ:NEXI

$0.01 +0.01 (+4,900.00%)
As of 09/12/2025 03:37 PM Eastern

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a product candidate targeted against HPV related cancers, which is in Phase I/II clinical trials. It provides NEXI-004 which is in preclinical stage for EBV related diseases; and NEXI005 designs for patient with specific targets for solid tumors. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.

Optec International stock logo

Optec International OTCMKTS:OPTI

$0.0011 0.00 (0.00%)
As of 03:14 PM Eastern

Optec International, Inc. engages in selling and marketing optimized fuel maximizer units in North America and internationally. It markets optimized fuel maximizer for passenger vehicles, intermediate/medium duty trucks, off-road equipment, generator systems, heavy duty diesel on-road vehicles, and transportation refrigeration units. The company was formerly known as Green Meadow Products, Inc. and changed its name to Optec International, Inc. in August 2017. Optec International, Inc. was founded in 2012 and is based in Carlsbad, California.